American Century Companies’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.1M Buy
487,031
+449,193
+1,187% +$29.2M 0.02% 860
2026
Q1
$1.8M Sell
37,838
-827,796
-96% -$37.1M ﹤0.01% 2156
2025
Q4
$27.5M Buy
865,634
+27,570
+3% +$860K 0.01% 1011
2025
Q3
$23.6M Sell
838,064
-26,320
-3% -$797K 0.01% 1063
2025
Q2
$31.8M Buy
864,384
+100,978
+13% +$3.49M 0.02% 868
2025
Q1
$30M Buy
763,406
+7,054
+0.9% +$318K 0.02% 846
2024
Q4
$35.1M Buy
756,352
+293,751
+63% +$13.3M 0.02% 782
2024
Q3
$20.9M Sell
462,601
-43,824
-9% -$2.09M 0.01% 1003
2024
Q2
$25M Sell
506,425
-275,691
-35% -$11.2M 0.02% 856
2024
Q1
$26.8M Buy
782,116
+719,897
+1,157% +$26M 0.02% 812
2023
Q4
$2.29M Buy
62,219
+18,617
+43% +$430K ﹤0.01% 1719
2023
Q3
$883K Buy
43,602
+26,769
+159% +$588K ﹤0.01% 2033
2023
Q2
$344K Buy
+16,833
New +$252K ﹤0.01% 2354

Other funds holding TWST

American Century Companies's TWST Position: Q2 2026 in Review

American Century Companies increased its Twist Bioscience (TWST) stake by 1,187% in Q2 2026, buying an estimated $29.2M and bringing the position to 487,031 shares worth $50.1M. The position accounts for 0.02% of the portfolio, ranked #860.

American Century Companies first reported a position in TWST in Q2 2023 and has held it in 13 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • American Century Companies held 487,031 shares of Twist Bioscience worth $50.1M as of Q2 2026.
  • American Century Companies bought 449,193 Twist Bioscience shares in Q2 2026, an estimated $29.2M.
  • Twist Bioscience made up 0.02% of American Century Companies's portfolio in Q2 2026, its #860 holding.
  • American Century Companies first reported a position in Twist Bioscience in Q2 2023 and has held it in 13 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.